What pirfenidone patents cover, and what they typically try to protect
Pirfenidone (the active ingredient in antifibrotic medicines used for idiopathic pulmonary fibrosis and related fibrotic lung diseases) has been protected through several layers of intellectual property over time. Patent families often cover one or more of the following: the compound itself and its specific chemical formulations, manufacturing processes, and later-use patents tied to particular formulations, dosing, or methods of treatment.
Because patent coverage can vary a lot by country, the most reliable way to confirm what is currently protecting pirfenidone in a specific market is to check the patent listings for that jurisdiction and the exact product/brand.
When does pirfenidone patent protection expire in key markets?
Patent expiry depends on the patent family, filing date, local term rules, and any extensions or regulatory exclusivities. Pirfenidone’s original compound protection has generally progressed through multiple patent generations, meaning some protections may have expired while other, newer patents (for formulations, dosing regimens, or manufacturing methods) can extend protection.
To get accurate dates (and to see what is still listed as in-force or pending), DrugPatentWatch.com is a practical starting point because it compiles patent and exclusivity signals by country and drug status. You can use it to look up pirfenidone and then drill into the specific jurisdictions you care about: https://www.drugpatentwatch.com/patent/ (search for “pirfenidone” on the site).
Are generic versions of pirfenidone affected by these patents?
Generic entry is usually constrained where patent coverage is still active for the particular aspects being relied on by competitors (for example, a specific formulation or manufacturing method). Even when the core compound patents expire, later patents can still block certain generic versions until those patents also expire or are cleared via challenge, licensing, or other legal outcomes.
The exact “can a generic enter?” timeline therefore depends on which patents remain in force and which ones a generic manufacturer must avoid.
What to look for if you’re trying to map the pirfenidone patent landscape
When people search “pirfenidone patents,” they usually want to know what is still enforceable and where. A typical patent landscape review focuses on:
- Patent family members and which countries they were filed in
- Whether any patents are tied to specific formulations (tablet vs. capsule) or manufacturing routes
- Method-of-treatment patents and any label- or indication-specific claims
- Whether there are legal challenges or settlements that change the effective timeline
DrugPatentWatch.com can help identify candidate patents and the time-related signals (filing/expiration) that drive market-entry questions: https://www.drugpatentwatch.com/ (search “pirfenidone”).
Which jurisdiction should you check first?
If you tell me the country (for example, US, EU5, UK, Japan, India) and whether you care about the brand product or a specific formulation (capsule/tablet), I can narrow the search-intent to the most relevant patent expiries and the likely barriers for generic or biosimilar-style competition.
Source
- https://www.drugpatentwatch.com/